Free Trial

Colgate-Palmolive (NYSE:CL) Receives Hold (C) Rating from Weiss Ratings

Colgate-Palmolive logo with Consumer Staples background

Key Points

  • Colgate-Palmolive received a "hold (c)" rating from Weiss Ratings, reflecting analysts' cautious stance on the stock amidst fluctuating price projections from various financial institutions.
  • Recent ratings adjustments included a price target reduction by JPMorgan Chase & Co. from $95.00 to $88.00 and by UBS Group from $99.00 to $92.00, suggesting a mixed outlook on the stock's performance.
  • The company's stock closed at $78.01 after trading down $0.44, with a market capitalization of approximately $63.05 billion and an average price target of $91.50 according to analyst consensus.
  • Five stocks to consider instead of Colgate-Palmolive.

Colgate-Palmolive (NYSE:CL - Get Free Report)'s stock had its "hold (c)" rating reaffirmed by analysts at Weiss Ratings in a research note issued on Friday,Weiss Ratings reports.

CL has been the topic of several other reports. JPMorgan Chase & Co. decreased their price objective on shares of Colgate-Palmolive from $95.00 to $88.00 and set an "overweight" rating on the stock in a research note on Friday, October 10th. UBS Group reduced their target price on shares of Colgate-Palmolive from $99.00 to $92.00 and set a "buy" rating on the stock in a research report on Wednesday, October 8th. Barclays lowered their price target on shares of Colgate-Palmolive from $87.00 to $82.00 and set an "equal weight" rating for the company in a report on Wednesday, October 1st. Piper Sandler began coverage on shares of Colgate-Palmolive in a report on Friday, October 3rd. They issued a "neutral" rating and a $84.00 price target for the company. Finally, Wells Fargo & Company lowered their price target on shares of Colgate-Palmolive from $83.00 to $80.00 and set an "underweight" rating for the company in a report on Thursday, September 25th. Eight equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $91.50.

Check Out Our Latest Analysis on Colgate-Palmolive

Colgate-Palmolive Price Performance

Colgate-Palmolive stock traded down $0.44 during trading hours on Friday, hitting $78.01. 4,247,437 shares of the stock were exchanged, compared to its average volume of 5,933,891. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89. The stock has a market capitalization of $63.05 billion, a P/E ratio of 21.91, a P/E/G ratio of 4.60 and a beta of 0.34. Colgate-Palmolive has a 12 month low of $76.68 and a 12 month high of $100.18. The business's 50-day moving average is $81.33 and its two-hundred day moving average is $86.94.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings data on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, topping the consensus estimate of $0.89 by $0.03. The firm had revenue of $5.11 billion for the quarter, compared to analysts' expectations of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The company's quarterly revenue was up 1.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.91 earnings per share. Equities research analysts expect that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Hedge Funds Weigh In On Colgate-Palmolive

Large investors have recently bought and sold shares of the business. Westend Capital Management LLC lifted its holdings in Colgate-Palmolive by 111.1% in the first quarter. Westend Capital Management LLC now owns 266 shares of the company's stock valued at $25,000 after buying an additional 140 shares during the period. Westside Investment Management Inc. lifted its holdings in Colgate-Palmolive by 85.5% in the second quarter. Westside Investment Management Inc. now owns 282 shares of the company's stock valued at $26,000 after buying an additional 130 shares during the period. Cornerstone Planning Group LLC lifted its holdings in Colgate-Palmolive by 1,913.3% in the first quarter. Cornerstone Planning Group LLC now owns 302 shares of the company's stock valued at $28,000 after buying an additional 287 shares during the period. Saudi Central Bank acquired a new position in Colgate-Palmolive in the first quarter valued at approximately $29,000. Finally, Vermillion & White Wealth Management Group LLC lifted its holdings in Colgate-Palmolive by 86.1% in the second quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company's stock valued at $30,000 after buying an additional 155 shares during the period. 80.41% of the stock is currently owned by institutional investors and hedge funds.

About Colgate-Palmolive

(Get Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.